...
首页> 外文期刊>AIDS >Protease inhibitor monotherapy is not associated with increased viral replication in lymph nodes
【24h】

Protease inhibitor monotherapy is not associated with increased viral replication in lymph nodes

机译:蛋白酶抑制剂单一疗法与淋巴结中病毒复制增加无关

获取原文
获取原文并翻译 | 示例
           

摘要

There are concerns about residual viremia in sanctuary sites among patients on protease inhibitor monotherapy, so we aimed to study viro-immunological parameters in tonsilê1/4s lymphoid tissue of patients on highly active antiretroviral therapy (HAART) and on protease inhibitor monotherapy. Despite fully suppressed serum HIV viral load, we found viral replication in both groups; in addition, more patients had detectable proviral DNA among those on HAART, compared to those on protease inhibitor monotherapy (P=0.08), supporting the absence of a deleterious effect of protease inhibitor monotherapy.
机译:对于使用蛋白酶抑制剂单一疗法的患者中,圣所中残留的病毒血症存在担忧,因此我们旨在研究采用高活性抗逆转录病毒疗法(HAART)和蛋白酶抑制剂单一疗法的患者扁桃体1 / 4s淋巴组织的病毒免疫学参数。尽管完全抑制了血清HIV病毒载量,但两组均发现病毒复制。此外,与使用蛋白酶抑制剂单一疗法的患者相比,使用HAART的患者中可检出前病毒DNA的患者更多(P = 0.08),这表明缺乏蛋白酶抑制剂单一疗法的有害作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号